Acute Myeloid Leukemia Clinical Trials in Moscow
4 recruitingMoscow, Russia
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology64 enrolled1 locationNCT07366801
Recruiting
Phase 3
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Acute Myeloid Leukemia
Ascentage Pharma Group Inc.486 enrolled6 locationsNCT06389292
Recruiting
Phase 2
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
Acute Myeloid LeukemiaMixed Phenotype Acute LeukemiaAcute Lymphoblastic T-cell Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology15 enrolled1 locationNCT07256210
Recruiting
Phase 3
IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML
Refractory Acute Myeloid LeukemiaEarly Relapses of Acute Myeloid Leukemia
National Research Center for Hematology, Russia198 enrolled1 locationNCT06418776